A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong A Hong Kong tuberculosis treatment services/Brompton hospital/British medical research council investigation
Authors:
- AhongkongtuberculosistreatmentAHAhongkongtuberculosistreatment
- RESEARCHRERESEARCH